Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 9 studies | 27% ± 11% | |
GABAergic neuron | 7 studies | 37% ± 20% | |
interneuron | 6 studies | 34% ± 20% | |
glutamatergic neuron | 5 studies | 52% ± 22% | |
epithelial cell | 5 studies | 28% ± 6% | |
fibroblast | 5 studies | 20% ± 5% | |
astrocyte | 5 studies | 32% ± 8% | |
oligodendrocyte | 5 studies | 25% ± 6% | |
macrophage | 4 studies | 25% ± 5% | |
neuron | 4 studies | 30% ± 8% | |
pericyte | 4 studies | 19% ± 2% | |
oligodendrocyte precursor cell | 4 studies | 32% ± 10% | |
endothelial cell of lymphatic vessel | 4 studies | 18% ± 2% | |
granule cell | 3 studies | 24% ± 3% | |
microglial cell | 3 studies | 23% ± 1% | |
ciliated cell | 3 studies | 23% ± 3% | |
non-classical monocyte | 3 studies | 22% ± 6% | |
transit amplifying cell | 3 studies | 22% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2386.40 | 1445 / 1445 | 100% | 16.52 | 183 / 183 |
intestine | 100% | 2621.51 | 966 / 966 | 100% | 17.60 | 527 / 527 |
ovary | 100% | 2832.50 | 180 / 180 | 100% | 15.69 | 430 / 430 |
prostate | 100% | 2412.84 | 245 / 245 | 100% | 18.50 | 502 / 502 |
stomach | 100% | 1710.43 | 359 / 359 | 100% | 17.50 | 286 / 286 |
breast | 100% | 2191.09 | 459 / 459 | 100% | 21.78 | 1117 / 1118 |
brain | 100% | 2339.53 | 2637 / 2642 | 100% | 23.11 | 705 / 705 |
lung | 100% | 2034.49 | 576 / 578 | 100% | 15.99 | 1155 / 1155 |
bladder | 100% | 2347.86 | 21 / 21 | 100% | 14.55 | 502 / 504 |
uterus | 100% | 2898.35 | 170 / 170 | 100% | 16.41 | 457 / 459 |
thymus | 100% | 2400.65 | 653 / 653 | 100% | 16.86 | 602 / 605 |
adrenal gland | 100% | 2611.47 | 258 / 258 | 99% | 20.14 | 228 / 230 |
kidney | 100% | 1952.75 | 89 / 89 | 99% | 15.51 | 892 / 901 |
pancreas | 100% | 1124.88 | 327 / 328 | 98% | 13.19 | 175 / 178 |
skin | 100% | 2106.60 | 1806 / 1809 | 96% | 13.59 | 452 / 472 |
liver | 100% | 949.65 | 225 / 226 | 93% | 6.99 | 376 / 406 |
adipose | 100% | 2163.56 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2974.11 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 15.10 | 29 / 29 |
muscle | 100% | 1658.13 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2022.57 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 12.66 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.45 | 1 / 1 |
heart | 98% | 1750.24 | 848 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 10.91 | 74 / 80 |
peripheral blood | 88% | 1433.43 | 813 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0009301 | Biological process | snRNA transcription |
GO_0042796 | Biological process | snRNA transcription by RNA polymerase III |
GO_0042795 | Biological process | snRNA transcription by RNA polymerase II |
GO_0006383 | Biological process | transcription by RNA polymerase III |
GO_0005730 | Cellular component | nucleolus |
GO_0016604 | Cellular component | nuclear body |
GO_0005654 | Cellular component | nucleoplasm |
GO_0019185 | Cellular component | snRNA-activating protein complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0003681 | Molecular function | bent DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0000995 | Molecular function | RNA polymerase III general transcription initiation factor activity |
GO_0001046 | Molecular function | core promoter sequence-specific DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0001006 | Molecular function | RNA polymerase III type 3 promoter sequence-specific DNA binding |
Gene name | SNAPC3 |
Protein name | snRNA-activating protein complex subunit 3 (Small nuclear RNA-activating complex polypeptide 3) snRNA-activating protein complex subunit 3 (SNAPc subunit 3) (Proximal sequence element-binding transcription factor subunit beta) (PSE-binding factor subunit beta) (PTF subunit beta) (Small nuclear RNA-activating complex polypeptide 3) (snRNA-activating protein complex 50 kDa subunit) (SNAPc 50 kDa subunit) |
Synonyms | SNAP50 |
Description | FUNCTION: Part of the SNAPc complex required for the transcription of both RNA polymerase II and III small-nuclear RNA genes. Binds to the proximal sequence element (PSE), a non-TATA-box basal promoter element common to these 2 types of genes. Recruits TBP and BRF2 to the U6 snRNA TATA box. . FUNCTION: Part of the SNAPc complex required for the transcription of both RNA polymerase II and III small-nuclear RNA genes. Binds to the proximal sequence element (PSE), a non-TATA-box basal promoter element common to these 2 types of genes. Recruits TBP and BRF2 to the U6 snRNA TATA box. . FUNCTION: Part of the SNAPc complex required for the transcription of both RNA polymerase II and III small-nuclear RNA genes. Binds to the proximal sequence element (PSE), a non-TATA-box basal promoter element common to these 2 types of genes. Recruits TBP and BRF2 to the U6 snRNA TATA box. . |
Accessions | Q5T284 Q92966 ENST00000380799.1 ENST00000467062.5 ENST00000610884.4 ENST00000380821.8 ENST00000490969.5 ENST00000421710.5 Q5T282 |